Marshall Gordon is a health care analyst at Clear Bridge Advisors, a New York based asset manager with an AUM of $55B.
"I think we are beginning to see signs of life amongst biotechs, with new products coming to market that are gaining traction. Innovation is a great way to get paid, in any market environment or regulatory environment."
"I think we are beginning to see signs of life amongst biotechs, with new products coming to market that are gaining traction. Innovation is a great way to get paid, in any market environment or regulatory environment."
No comments:
Post a Comment